SCHEDULE: JPMorgan Chase Discloses 1.7% Stake in Hims & Hers Health

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, reporting a 1.7% beneficial ownership in Hims & Hers Health, Inc.'s Class A common stock.

Summary

• JPMorgan Chase & Co. beneficially owns 3,881,790 shares of Hims & Hers Health, Inc. Class A common stock.
• This ownership represents 1.7% of the Class A common stock outstanding.
• JPMorgan Chase & Co. holds sole voting power over 3,399,965 shares and shared voting power over 13 shares.
• The firm has sole dispositive power over 3,879,553 shares and shared dispositive power over 2,145 shares.
• The filing was made as an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing.
• Several subsidiaries, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, are identified as having acquired the securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a routine disclosure of institutional ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures by institutional investors holding more than 5% of a company's stock, or by certain types of institutions (like banks or investment advisers) holding more than 5% in the ordinary course of business. This amendment indicates JPMorgan Chase & Co.'s updated position in Hims & Hers Health, Inc., reflecting ongoing portfolio management rather than a new, significant strategic move given the 1.7% stake.

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, confirming JPMorgan Chase & Co.'s continued, albeit non-controlling, interest in Hims & Hers Health, Inc.

Key Dates

Keywords

JPMorgan Chase, Hims & Hers Health, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Ownership